Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – EurekAlert
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
IMAGE: Volker M. Lauschke, associate professor
Department of Physiology and Pharmacology, Karolinska Institutet.
view more
Credit: Jannis Politidis
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing…
-
General23 hours agoBackward Bowen’s nuclearphobia is dangerous
-
General22 hours agoA-League Men live: City holds upper hand against Victory in grand final
-
Noosa News7 hours ago“Why Did You Keep Me Alive?”: Netflix Has Pressed the Button on the Full Trailer for ‘Squid Game’ Season Three
-
General6 hours agoGhost towns that were once bustling gold mining, farming, railway hubs